Evaluating a Peptide-Based T-Cell Activating COVID-19 vaccine – Insights from a Phase I/II Trial
T-cell immunity plays a crucial role in controlling COVID-19, especially in individuals who cannot generate antibody responses. Researchers have recently developed a peptide based T cell vaccine candidate CoVac-1. CoVac-1…
StefanAugust 24, 2023




















































































![The current TB vaccine pipeline (last update September 2019). Source: TuBerculosis Vaccine Intitiative (TBVI) [tbvi.eu/what-we-do/pipeline-of-vaccines/]](https://new.immunopaedia.com/wp-content/uploads/2019/10/Screenshot-2019-10-28-at-08.02.16.png)







![This illustration depicts a three-dimensional (3D) computer-generated image of a group of aerobic, Gram-negative, Bordetella pertussis bacteria. The artistic recreation was based upon scanning electron microscopic (SEM) imagery. [Source: CDC PHIL: CDC/ Sarah Bailey Cutchin]](https://new.immunopaedia.com/wp-content/uploads/2019/06/250619.jpg)



